NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
Norges Bank acquired a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional ...
Progressive Multifocal Leukoencephalopathy (PML): Although no cases of PML have occurred in BRIUMVI-treated MS patients, JCV infection resulting in PML has been observed in patients treated with other ...
The Red Sox outfielder's candor in discussing his problems has focused attention on players who not only suffer but do so in ...
A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper ...
Incidence of invasive group A Streptococcus infections more than doubled in 10 states over a 9-year period ending in 2022, a ...
Daniel Drucker, the Canadian scientist renowned for discoveries that sparked the advent of Ozempic and other GLP-1 medicines ...
Cells throughout the body work together like singers in a choir to keep us healthy, as long as they work in perfect harmony.